TRT / RTR Design [RSABE / ABEL]

posted by mittyri  – Russia, 2017-05-02 20:38 (3344 d 10:38 ago) – Posting: # 17295
Views: 12,325

Dear Yura,

you should use all data included in PK analysis (ie all subjects) for CI estimation.
To extent the limits you need to calculate variability of RR, that is, 50% of subjects.
A hint: even if you try to calculate variability of RR for overall dataset, the majority of software (at least SAS PHX, R) is smart enough not to include the subjects with one R.

❝ The appropriate sample size must be.

❝ Alpha correction.

what did you mean here?

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
359 visitors (0 registered, 359 guests [including 23 identified bots]).
Forum time: 07:17 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5